Adrienne M. Flanagan

University College London
United Kingdom

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 84 Citations 38,806 303 World Ranking 9811 National Ranking 926

Overview

What are the main themes of her work throughout her whole career to date

Exome sequencing and ATRX are the subject areas of her Mutation study. In her study, Adrienne M. Flanagan carries out multidisciplinary Exome sequencing and Gene research. She conducted interdisciplinary study in her works that combined Gene and ATRX. Pathology is integrated with Malignancy and Lesion in her study. Malignancy and Mutation are two areas of study in which Adrienne M. Flanagan engages in interdisciplinary work. Her research brings together the fields of Aneurysmal bone cyst and Lesion. In her works, she undertakes multidisciplinary study on Aneurysmal bone cyst and Chondroblastoma. Her study in Pathology extends to Chondroblastoma with its themes. Adrienne M. Flanagan undertakes multidisciplinary studies into Genetics and Cancer research in her work.

Adrienne M. Flanagan most often published in these fields:

Genetics (100.00%)
Gene (100.00%)
Giant cell (50.00%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Mutations of the BRAF gene in human cancer

Helen Davies;Graham R. Bignell;Charles Cox;Philip Stephens.
Nature (2002)

11646 Citations

Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development

Philip J. Stephens;Chris D. Greenman;Beiyuan Fu;Fengtang Yang.
Cell (2011)

2258 Citations

Pan-cancer analysis of whole genomes

Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart.
(2020)

1275 Citations

The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

S Bamford;E Dawson;S Forbes;J Clements.
British Journal of Cancer (2004)

1221 Citations

Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee: a prospective, randomised study.

W. Bartlett;J. A. Skinner;C. R. Gooding;R. W. J. Carrington.
Journal of Bone and Joint Surgery-british Volume (2005)

997 Citations

IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours

M. Fernanda Amary;Krisztian Bacsi;Francesca Maggiani;Stephen Damato.
The Journal of Pathology (2011)

902 Citations

Lung cancer: intragenic ERBB2 kinase mutations in tumours.

Philip Stephens;Chris Hunter;Graham Bignell;Sarah Edkins.
Nature (2004)

754 Citations

Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone.

Sam Behjati;Sam Behjati;Patrick S Tarpey;Nadège Presneau;Susanne Scheipl;Susanne Scheipl.
Nature Genetics (2013)

635 Citations

Somatic Mutations of the Protein Kinase Gene Family in Human Lung Cancer

Helen Davies;Chris Hunter;Raffaella Smith;Philip Stephens.
Cancer Research (2005)

553 Citations

Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas

S Vujovic;S Henderson;N Presneau;Edward Odell.
The Journal of Pathology (2006)

521 Citations

If you think any of the details on this page are incorrect, let us know.

Frequent Co-Authors

External Links

Personal Website for Adrienne M. Flanagan